Researcher turns a personal diagnosis into a scientific quest
Dr. Tyler Nelson's diagnosis of periodic paralysis inspired a new focus in his work as a young neuroscientist at the MBI.
Dr. Tyler Nelson's diagnosis of periodic paralysis inspired a new focus in his work as a young neuroscientist at the MBI.
In the lab of MBI researcher Dr. Catherine Flores, M.D.-Ph.D. student Cali Love is developing therapies for glioblastoma.
Congratulations to Dr. Matthew Gentry, who received a $100,000 Oxford-Harrington Rare Disease Centre’s 2025 Rare Disease Scholar Award.
The Alzheimer's Research Foundation provided a $100,000 gift to the MBI to support early-career scientists in the field.
Dr. Aliyah Snyder led a new study that found current tools for evaluating TBI in menopausal women may overlook how hormone changes affect recovery.
Drs. Carol Mathews and Joseph McNamara discuss how fear affects the brain and body.
Drs. Adithya Gopinath and Zachary Sorrentino earn awards given to researchers whose early-stage projects hold potential to drive meaningful scientific breakthroughs.
The MBI is accepting applications for an award offering $10,000 in-kind support to advance research using the 10x Genomics Visium HD platform. Applications due by Nov. 21, 2025.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.
Dr. Zahra Hasanpour-Segherlou received a grant for her investigation into a new therapeutic strategy to protect the brain after subarachnoid hemorrhage.